Baidu
map

Open Forum Infect Dis:创伤后肌肉骨骼感染管理的多地点研究:MMUSKIT研究

2024-06-22 医路坦克 MedSci原创 发表于上海

骨折相关感染(FRI)的最佳持续时间和抗生素的选择尚未明确。本研究旨在确定抗生素持续时间(≤6周vs >6周)是否与无感染和无手术生存相关。第二个目的是确定与手术和无感染生存相关的危险因素。

骨折相关感染(FRI)是肌肉骨骼创伤的一种具有挑战性的并发症,可导致严重的发病率和死亡率。FRI的发生率因损伤严重程度而异,闭合性骨折的发生率为1.8%,开放性骨折的发生率为27%。FRI病例产生的医疗费用是未感染病例的6.5倍。FRI增加的成本和发病率是需要多次手术、抗生素治疗和长期康复的结果。FRI的治疗通常需要多次手术和长期的抗生素治疗,并且其复发率仍然很高。治疗FRI的成功率并不理想;在一项研究中,治疗成功率仅为70%,复发率为9%,截肢率为3%。不幸的是,FRI的最佳治疗方法尚不清楚,特别是关于抗生素治疗的选择和持续时间。一些作者建议根据感染的类型和严重程度、植入物的存在以及对治疗的反应进行6至12周的抗生素治疗。然而,缺乏证据支持这一建议。事实上,一些数据表明,对于骨和关节感染,较短疗程的抗生素治疗可能与较长疗程的抗生素治疗同样有效且危害更小。

本研究汇集了多个学术医疗中心的观察性数据,以评估抗生素治疗时间的差异是否与FRI治疗结果相关。本研究的主要目的是确定抗生素治疗时间≤6周vs >6周是否与无感染和无手术生存相关。第二个目的是评估与感染和无手术生存相关的因素。我们还评估了再次手术时对感染的担忧是否与再次手术患者使用抗生素的时间有关。最后,我们回顾了再次手术时复发感染的患者,以确定抗生素持续时间是否与再次手术时新病原体的鉴定相关

方法我们对2013年至2022年间诊断为FRI的患者进行了一项多中心回顾性研究。通过Cox比例风险模型评估抗生素持续时间与无手术和无感染生存之间的关系。模型通过倾向得分的倒数加权,用硬件移除的先验变量计算;金黄色葡萄球菌、卢氏葡萄球菌、假单胞菌或念珠菌感染;和皮瓣覆盖。采用多变量Cox比例风险模型,附加协变量包括初始病原体、皮瓣需求和硬体移除。

包含/排除标准

感染患者清创手术时的特点

无手术和无感染生存危险因素的Cox比例风险模型结果

Kaplan-Meier曲线的手术和无感染生存之间的抗生素持续时间组

结果96例患者中,54例(56.3%)≤6周,42例(43.7%)>6周。较长的抗生素使用时间与无手术生存无关联(风险比[HR], 0.95;95% CI, 0.65 - 1.38;P = 0.78)或无感染生存(HR, 0.77;95% CI, 0.30 - 1.96;P = .58)。阴性培养与再手术或死亡风险增加相关(HR, 3.52;95% CI, 1.99-6.20;P < 0.001)和再感染或死亡(HR, 3.71;95% CI, 1.24-11.09;P < 0.001)。对皮瓣覆盖的需求增加了再手术或死亡的风险(HR, 3.24;95% CI, 1.61-6.54;P = .001)。

结论抗生素治疗FRI的理想持续时间尚不清楚。在这项多中心研究中,抗生素治疗时间与无手术或无感染生存期之间没有关联。

原始出处:

Jessica, Seidelman;  Alaina S, Ritter;  Emily, Poehlein; Multisite Study of the Management of Musculoskeletal Infection After Trauma: The MMUSKIT Study.Open Forum Infect Dis 2024 Jun;11(6):ofae262

相关资料下载:
[AttachmentFileName(sort=1, fileName=PIIS2666639124000221.pdf)] GetArticleByIdResponse(id=65b883059383, projectId=1, sourceId=null, title=Open Forum Infect Dis:创伤后肌肉骨骼感染管理的多地点研究:MMUSKIT研究, articleFrom=MedSci原创, journalId=13352, copyright=原创, creationTypeList=[1], summary=骨折相关感染(FRI)的最佳持续时间和抗生素的选择尚未明确。本研究旨在确定抗生素持续时间(≤6周vs >6周)是否与无感染和无手术生存相关。第二个目的是确定与手术和无感染生存相关的危险因素。, cover=https://img.medsci.cn/20240618/1718704490473_92910.png, authorId=0, author=医路坦克, originalUrl=, linkOutUrl=, content=<p><span style="color: #000000;">骨折相关感染(FRI)是肌肉骨骼<a href="//m.capotfarm.com/topic/show?id=e7cc32022c7">创伤</a>的一种具有挑战性的并发症,可导致严重的发病率和死亡率。FRI的发生率因损伤严重程度而异,闭合性骨折的发生率为1.8%,开放性骨折的发生率为27%。FRI病例产生的医疗费用是未感染病例的6.5倍。FRI增加的成本和发病率是需要多次手术、<a href="//m.capotfarm.com/guideline/list.do?q=%E6%8A%97%E7%94%9F%E7%B4%A0">抗生素</a>治疗和长期康复的结果。FRI的治疗通常需要多次手术和长期的抗生素治疗,并且其复发率仍然很高。治疗FRI的成功率并不理想;在一项研究中,治疗成功率仅为70%,复发率为9%,截肢率为3%。</span><span style="color: #000000;">不幸的是,FRI的最佳治疗方法尚不清楚,特别是关于抗生素治疗的选择和持续时间。一些作者建议根据感染的类型和严重程度、植入物的存在以及对治疗的反应进行6至12周的抗生素治疗。然而,缺乏证据支持这一建议。事实上,一些数据表明,对于骨和关节感染,较短疗程的抗生素治疗可能与较长疗程的抗生素治疗同样有效且危害更小。</span></p> <p><span style="color: #000000;"><img style="display: block; margin-left: auto; margin-right: auto;" src="https://img.medsci.cn/20240617/1718609105254_2269929.png" /></span></p> <p><span style="color: #000000;">本研究汇集了多个学术医疗中心的观察性数据,以评估抗生素治疗时间的差异是否与FRI治疗结果相关。本研究的主要目的是确定抗生素治疗时间&le;6周vs &gt;6周是否与无感染和无手术生存相关。第二个目的是评估与感染和无手术生存相关的因素。我们还评估了再次手术时对感染的担忧是否与再次手术患者使用抗生素的时间有关。最后,我们回顾了再次手术时复发感染的患者,以确定抗生素持续时间是否与再次手术时新病原体的鉴定相关</span><span style="color: #000000;">。</span></p> <p><span style="color: #000000;">方法</span><span style="color: #000000;">:</span><span style="color: #000000;">我们对2013年至2022年间<a href="//m.capotfarm.com/guideline/list.do?q=%E8%AF%8A%E6%96%AD">诊断</a>为FRI的患者进行了一项多中心回顾性研究。通过Cox比例风险模型评估抗生素持续时间与无手术和无感染生存之间的关系。模型通过倾向得分的倒数加权,用硬件移除的先验变量计算;金黄色葡萄球菌、卢氏葡萄球菌、假单胞菌或念珠菌感染;和皮瓣覆盖。采用多变量Cox比例风险模型,附加协变量包括初始病原体、皮瓣需求和硬体移除。</span></p> <p><span style="color: #000000;"><img style="display: block; margin-left: auto; margin-right: auto;" src="https://img.medsci.cn/20240617/1718609105262_2269929.png" /></span></p> <p style="text-align: center;"><span style="color: #000000;">包含/排除标准</span></p> <p style="text-align: center;"><span style="color: #000000;"><img src="https://img.medsci.cn/20240617/1718609105266_2269929.png" /></span></p> <p style="text-align: center;"><span style="color: #000000;">感染患者清创手术时的特点</span></p> <p style="text-align: center;"><span style="color: #000000;"><img src="https://img.medsci.cn/20240617/1718609105267_2269929.png" /></span></p> <p style="text-align: center;"><span style="color: #000000;">无手术和无感染生存危险因素的Cox比例风险模型结果</span></p> <p style="text-align: center;"><span style="color: #000000;"><img src="https://img.medsci.cn/20240617/1718609105270_2269929.png" /></span></p> <p style="text-align: center;"><span style="color: #000000;">Kaplan-Meier曲线的手术和无感染生存之间的抗生素持续时间组</span></p> <p><span style="color: #000000;">结果</span><span style="color: #000000;">:</span><span style="color: #000000;">96例患者中,54例(56.3%)&le;6周,42例(43.7%)&gt;6周。较长的抗生素使用时间与无手术生存无关联(风险比[HR], 0.95;95% </span><span style="color: #000000;">CI</span><span style="color: #000000;">, 0.65 - 1.38;P = 0.78)或无感染生存(HR, 0.77;95% </span><span style="color: #000000;">CI</span><span style="color: #000000;">, 0.30 - 1.96;P = .58)。阴性培养与再手术或死亡风险增加相关(HR, 3.52;95% </span><span style="color: #000000;">CI</span><span style="color: #000000;">, 1.99-6.20;P &lt; 0.001)和再感染或死亡(HR, 3.71;95% </span><span style="color: #000000;">CI</span><span style="color: #000000;">, 1.24-11.09;P &lt; 0.001)。对皮瓣覆盖的需求增加了再手术或死亡的风险(HR, 3.24;95% </span><span style="color: #000000;">CI</span><span style="color: #000000;">, 1.61-6.54;P = .001)。</span></p> <p><span style="color: #000000;">结论</span><span style="color: #000000;">:</span><span style="color: #000000;">抗生素治疗FRI的理想持续时间尚不清楚。在这项多中心研究中,抗生素治疗时间与无手术或无感染生存期之间没有关联。</span></p> <p><span style="color: #808080; font-size: 12px;"><a style="color: #808080;" href="https://watermark.silverchair.com/ofae262.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAA1AwggNMBgkqhkiG9w0BBwagggM9MIIDOQIBADCCAzIGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM-icd_YcmhKh8_8xUAgEQgIIDA0x1nJcB3_xgBqBygUFGWwfF_Bgds-Z5gtKTZW6Ku2-irEg8ZKXEPqE8bpHksDkJl0CZ4v55KPf4ZYGa2qw71liznijr8dD8jMkymRWRp98EG4g1EPntVEi4EbmTw66tjfzV6k-Q2dGKM-NbakB2v3ygb7_VCybcahdjYYPNrGkZ7t5AQ11xJwdp6Ccr3bxxu57hYNq3rO5iZeapZBC5SvwbBGpm1HmkzRQxT42abu1lD-XY-Hw2wh6MfcM_DeQ222AFhsxsFxPTV9u2iLVOby07UxT-YdhOMJHMiXbPF8BUu-XsCH-IenELhioIRoLFtMC6A8H1lw4KvDg7HIQ3FDrKlQ1cIMO7IHdfGRdyAt8N8-HWvER_4xMyUui8C_q1z4GhW0flJtFrl3V_CjL-3q3KYRJv-4nKulcZEyxKoP6vZCNhGrd98-bPGoig_8Rk7-sRQXOHkTYDu6Z7DCm6Ke-e7wZwefdq_NDn9A2nH5RhHtr_1LZ7crm9CCTvqDIdhWStDP0NJahFOtqxCW-PqfyEsdufmhR15FlklBO78TlXj5a_AtHAE075wx2M2pOw1k61v0Ow3I_H--nTKJMG1IrnBnhhzTR-qI_FCCmbWDWxeidkkSKzgNoXSO8qcbYZUMGbUBRHYBT31WCu2qQuw5olUauxdgVZw1_xqjtOByVK5yF9Jxn8r2RKAr6Ebf0t6MOiWZCIxQzB3AH--cGrWEJl7NpGyKJz1VtAd6ncRL3cPhmdI-378JMNtLK6WgvdLWxA531uXeALswR-wjk5XSDdZM6suTsMGjkfsviYFUw7UDAD5nl4vnju81xiiMElygYL1ukOa-k3_SrJ7xBqAiDuW_MY4P6AzSxcewfL0R4pCGGIS2FDjyNrt0hSiCym5POJmLyjCjzi5PazluV1UM_gTp_obwdymIxQ4X-49_cibm9QD8PR5mfqXhY4GYiqPA83Tj-ksJ5y6DTMcVI6H5RZeBmfB0Z5cd_IX8Ybds3C9rQIYDQVv66W5MWLz08uLfC_oQ" target="_blank" rel="noopener">原始出处:</a></span></p> <p><span style="color: #808080; font-size: 12px;"><a style="color: #808080;" href="https://watermark.silverchair.com/ofae262.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAA1AwggNMBgkqhkiG9w0BBwagggM9MIIDOQIBADCCAzIGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM-icd_YcmhKh8_8xUAgEQgIIDA0x1nJcB3_xgBqBygUFGWwfF_Bgds-Z5gtKTZW6Ku2-irEg8ZKXEPqE8bpHksDkJl0CZ4v55KPf4ZYGa2qw71liznijr8dD8jMkymRWRp98EG4g1EPntVEi4EbmTw66tjfzV6k-Q2dGKM-NbakB2v3ygb7_VCybcahdjYYPNrGkZ7t5AQ11xJwdp6Ccr3bxxu57hYNq3rO5iZeapZBC5SvwbBGpm1HmkzRQxT42abu1lD-XY-Hw2wh6MfcM_DeQ222AFhsxsFxPTV9u2iLVOby07UxT-YdhOMJHMiXbPF8BUu-XsCH-IenELhioIRoLFtMC6A8H1lw4KvDg7HIQ3FDrKlQ1cIMO7IHdfGRdyAt8N8-HWvER_4xMyUui8C_q1z4GhW0flJtFrl3V_CjL-3q3KYRJv-4nKulcZEyxKoP6vZCNhGrd98-bPGoig_8Rk7-sRQXOHkTYDu6Z7DCm6Ke-e7wZwefdq_NDn9A2nH5RhHtr_1LZ7crm9CCTvqDIdhWStDP0NJahFOtqxCW-PqfyEsdufmhR15FlklBO78TlXj5a_AtHAE075wx2M2pOw1k61v0Ow3I_H--nTKJMG1IrnBnhhzTR-qI_FCCmbWDWxeidkkSKzgNoXSO8qcbYZUMGbUBRHYBT31WCu2qQuw5olUauxdgVZw1_xqjtOByVK5yF9Jxn8r2RKAr6Ebf0t6MOiWZCIxQzB3AH--cGrWEJl7NpGyKJz1VtAd6ncRL3cPhmdI-378JMNtLK6WgvdLWxA531uXeALswR-wjk5XSDdZM6suTsMGjkfsviYFUw7UDAD5nl4vnju81xiiMElygYL1ukOa-k3_SrJ7xBqAiDuW_MY4P6AzSxcewfL0R4pCGGIS2FDjyNrt0hSiCym5POJmLyjCjzi5PazluV1UM_gTp_obwdymIxQ4X-49_cibm9QD8PR5mfqXhY4GYiqPA83Tj-ksJ5y6DTMcVI6H5RZeBmfB0Z5cd_IX8Ybds3C9rQIYDQVv66W5MWLz08uLfC_oQ" target="_blank" rel="noopener">Jessica, Seidelman;&nbsp;&nbsp;Alaina S, Ritter;&nbsp;&nbsp;Emily, Poehlein;&nbsp;Multisite Study of the Management of Musculoskeletal Infection After Trauma: The MMUSKIT Study.Open Forum Infect Dis&nbsp;2024 Jun;11(6):ofae262</a></span></p>, belongTo=, tagList=[TagDto(tagId=756, tagName=创伤), TagDto(tagId=486321, tagName=肌肉骨骼感染), TagDto(tagId=491923, tagName=MMUSKIT研究)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=84, categoryName=研究进展, tenant=100), CategoryDto(categoryId=20656, categoryName=梅斯医学, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, opened=1, paymentType=1, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1142, appHits=29, showAppHits=0, pcHits=28, showPcHits=1113, likes=0, shares=16, comments=5, approvalStatus=1, publishedTime=Sat Jun 22 15:00:00 CST 2024, publishedTimeString=2024-06-22, pcVisible=1, appVisible=1, editorId=6556091, editor=骨科新前沿, waterMark=0, formatted=0, deleted=0, version=3, createdBy=893e2269929, createdName=医路坦克, createdTime=Mon Jun 17 15:25:46 CST 2024, updatedBy=92910, updatedName=rayms, updatedTime=Tue Jun 18 17:55:06 CST 2024, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=PIIS2666639124000221.pdf)], guideDownload=1)
PIIS2666639124000221.pdf
版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2211310, encodeId=cf27221131040, content=学习前沿知识紧跟时代潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c53431821, createdName=13013f32m56暂无昵称, createdTime=Mon Jun 24 05:45:49 CST 2024, time=2024-06-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211184, encodeId=3f2a221118468, content=好文章,好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Jun 22 23:51:30 CST 2024, time=2024-06-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2211169, encodeId=1d6f22111699b, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Sat Jun 22 21:16:58 CST 2024, time=2024-06-22, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2211166, encodeId=9f0a2211166f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jun 22 20:42:56 CST 2024, time=2024-06-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2211153, encodeId=43bb2211153d7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/e427544c3e524f2bb6586cfaebefcf3a/043f03787c2f41108b03e5fe4355ad93.jpg, createdBy=f6868411808, createdName=一路生花, createdTime=Sat Jun 22 16:05:08 CST 2024, time=2024-06-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2210525, encodeId=a1032210525ce, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a> <a href='/topic/show?id=53971106895f' target=_blank style='color:#2F92EE;'>#肌肉骨骼感染#</a> <a href='/topic/show?id=27471156553c' target=_blank style='color:#2F92EE;'>#MMUSKIT研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=115655, encryptionId=27471156553c, topicName=MMUSKIT研究), TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤), TopicDto(id=110689, encryptionId=53971106895f, topicName=肌肉骨骼感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Tue Jun 18 17:55:06 CST 2024, time=2024-06-18, status=1, ipAttribution=上海)]
    2024-06-24 13013f32m56暂无昵称 来自河北省

    学习前沿知识紧跟时代潮流

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2211310, encodeId=cf27221131040, content=学习前沿知识紧跟时代潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c53431821, createdName=13013f32m56暂无昵称, createdTime=Mon Jun 24 05:45:49 CST 2024, time=2024-06-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211184, encodeId=3f2a221118468, content=好文章,好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Jun 22 23:51:30 CST 2024, time=2024-06-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2211169, encodeId=1d6f22111699b, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Sat Jun 22 21:16:58 CST 2024, time=2024-06-22, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2211166, encodeId=9f0a2211166f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jun 22 20:42:56 CST 2024, time=2024-06-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2211153, encodeId=43bb2211153d7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/e427544c3e524f2bb6586cfaebefcf3a/043f03787c2f41108b03e5fe4355ad93.jpg, createdBy=f6868411808, createdName=一路生花, createdTime=Sat Jun 22 16:05:08 CST 2024, time=2024-06-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2210525, encodeId=a1032210525ce, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a> <a href='/topic/show?id=53971106895f' target=_blank style='color:#2F92EE;'>#肌肉骨骼感染#</a> <a href='/topic/show?id=27471156553c' target=_blank style='color:#2F92EE;'>#MMUSKIT研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=115655, encryptionId=27471156553c, topicName=MMUSKIT研究), TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤), TopicDto(id=110689, encryptionId=53971106895f, topicName=肌肉骨骼感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Tue Jun 18 17:55:06 CST 2024, time=2024-06-18, status=1, ipAttribution=上海)]
    2024-06-22 yangchou 来自浙江省

    好文章,好文章,谢谢分享。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2211310, encodeId=cf27221131040, content=学习前沿知识紧跟时代潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c53431821, createdName=13013f32m56暂无昵称, createdTime=Mon Jun 24 05:45:49 CST 2024, time=2024-06-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211184, encodeId=3f2a221118468, content=好文章,好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Jun 22 23:51:30 CST 2024, time=2024-06-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2211169, encodeId=1d6f22111699b, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Sat Jun 22 21:16:58 CST 2024, time=2024-06-22, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2211166, encodeId=9f0a2211166f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jun 22 20:42:56 CST 2024, time=2024-06-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2211153, encodeId=43bb2211153d7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/e427544c3e524f2bb6586cfaebefcf3a/043f03787c2f41108b03e5fe4355ad93.jpg, createdBy=f6868411808, createdName=一路生花, createdTime=Sat Jun 22 16:05:08 CST 2024, time=2024-06-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2210525, encodeId=a1032210525ce, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a> <a href='/topic/show?id=53971106895f' target=_blank style='color:#2F92EE;'>#肌肉骨骼感染#</a> <a href='/topic/show?id=27471156553c' target=_blank style='color:#2F92EE;'>#MMUSKIT研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=115655, encryptionId=27471156553c, topicName=MMUSKIT研究), TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤), TopicDto(id=110689, encryptionId=53971106895f, topicName=肌肉骨骼感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Tue Jun 18 17:55:06 CST 2024, time=2024-06-18, status=1, ipAttribution=上海)]
    2024-06-22 医鸣惊人 来自山西省

    认真学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2211310, encodeId=cf27221131040, content=学习前沿知识紧跟时代潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c53431821, createdName=13013f32m56暂无昵称, createdTime=Mon Jun 24 05:45:49 CST 2024, time=2024-06-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211184, encodeId=3f2a221118468, content=好文章,好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Jun 22 23:51:30 CST 2024, time=2024-06-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2211169, encodeId=1d6f22111699b, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Sat Jun 22 21:16:58 CST 2024, time=2024-06-22, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2211166, encodeId=9f0a2211166f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jun 22 20:42:56 CST 2024, time=2024-06-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2211153, encodeId=43bb2211153d7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/e427544c3e524f2bb6586cfaebefcf3a/043f03787c2f41108b03e5fe4355ad93.jpg, createdBy=f6868411808, createdName=一路生花, createdTime=Sat Jun 22 16:05:08 CST 2024, time=2024-06-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2210525, encodeId=a1032210525ce, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a> <a href='/topic/show?id=53971106895f' target=_blank style='color:#2F92EE;'>#肌肉骨骼感染#</a> <a href='/topic/show?id=27471156553c' target=_blank style='color:#2F92EE;'>#MMUSKIT研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=115655, encryptionId=27471156553c, topicName=MMUSKIT研究), TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤), TopicDto(id=110689, encryptionId=53971106895f, topicName=肌肉骨骼感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Tue Jun 18 17:55:06 CST 2024, time=2024-06-18, status=1, ipAttribution=上海)]
    2024-06-22 1209e435m98(暂无昵称) 来自浙江省

    学习了,谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2211310, encodeId=cf27221131040, content=学习前沿知识紧跟时代潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c53431821, createdName=13013f32m56暂无昵称, createdTime=Mon Jun 24 05:45:49 CST 2024, time=2024-06-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211184, encodeId=3f2a221118468, content=好文章,好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Jun 22 23:51:30 CST 2024, time=2024-06-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2211169, encodeId=1d6f22111699b, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Sat Jun 22 21:16:58 CST 2024, time=2024-06-22, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2211166, encodeId=9f0a2211166f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jun 22 20:42:56 CST 2024, time=2024-06-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2211153, encodeId=43bb2211153d7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/e427544c3e524f2bb6586cfaebefcf3a/043f03787c2f41108b03e5fe4355ad93.jpg, createdBy=f6868411808, createdName=一路生花, createdTime=Sat Jun 22 16:05:08 CST 2024, time=2024-06-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2210525, encodeId=a1032210525ce, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a> <a href='/topic/show?id=53971106895f' target=_blank style='color:#2F92EE;'>#肌肉骨骼感染#</a> <a href='/topic/show?id=27471156553c' target=_blank style='color:#2F92EE;'>#MMUSKIT研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=115655, encryptionId=27471156553c, topicName=MMUSKIT研究), TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤), TopicDto(id=110689, encryptionId=53971106895f, topicName=肌肉骨骼感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Tue Jun 18 17:55:06 CST 2024, time=2024-06-18, status=1, ipAttribution=上海)]
    2024-06-22 一路生花 来自山东省

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2211310, encodeId=cf27221131040, content=学习前沿知识紧跟时代潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c53431821, createdName=13013f32m56暂无昵称, createdTime=Mon Jun 24 05:45:49 CST 2024, time=2024-06-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211184, encodeId=3f2a221118468, content=好文章,好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Jun 22 23:51:30 CST 2024, time=2024-06-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2211169, encodeId=1d6f22111699b, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Sat Jun 22 21:16:58 CST 2024, time=2024-06-22, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2211166, encodeId=9f0a2211166f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jun 22 20:42:56 CST 2024, time=2024-06-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2211153, encodeId=43bb2211153d7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/e427544c3e524f2bb6586cfaebefcf3a/043f03787c2f41108b03e5fe4355ad93.jpg, createdBy=f6868411808, createdName=一路生花, createdTime=Sat Jun 22 16:05:08 CST 2024, time=2024-06-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2210525, encodeId=a1032210525ce, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a> <a href='/topic/show?id=53971106895f' target=_blank style='color:#2F92EE;'>#肌肉骨骼感染#</a> <a href='/topic/show?id=27471156553c' target=_blank style='color:#2F92EE;'>#MMUSKIT研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=115655, encryptionId=27471156553c, topicName=MMUSKIT研究), TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤), TopicDto(id=110689, encryptionId=53971106895f, topicName=肌肉骨骼感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Tue Jun 18 17:55:06 CST 2024, time=2024-06-18, status=1, ipAttribution=上海)]

相关资讯

Eur Radiol: 如何在CT图像上避免漏诊外伤患者的肋骨骨折?

肋骨骨折是钝性胸部外伤中最常见的创伤形式,发生于约50%的患者。诊断肋骨骨折的常规影像学检查是胸部X线平片。但是,这种方式的灵敏度较低,仅为15%。

Lancet子刊:聚焦创伤的认知行为治疗对儿童和青少年的疗效

研究结果支持CBTs-TF作为一线治疗,与年龄、性别、创伤特征或护理人员参与治疗无关,对那些初始痛苦程度较高的患者尤其有益。

Theranostics:小胞外囊泡疗法对伤口愈合和皮肤再生具有巨大的潜力

已有研究提议将小胞外囊泡(sEVs)作为目前缺乏内源性皮肤再生治疗干预的可能解决方案。

Neurology:扩大血管周围间隙内的豆纹动脉夹层

血肿位于10年前偶然发现的扩大的血管周围间隙(PVS)内。怀疑PVS内的豆纹动脉创伤性夹层是缺血性和出血事件的原因。

LANCET HEALTHY LONGEVITY:平时多锻炼,伤后预后好

该研究结果支持将CFS纳入创伤路径,以帮助患者管理。此外,定期锻炼的人(CFS为1-2)比活动水平较低的人(CFS≥3)有更好的预后,支持将锻炼作为改善创伤预后的干预措施。

Crit Care:血小板输注对创伤患者结局的影响

尽管入院时的血小板计数主要在正常范围内,但它与创伤严重程度和凝血功能障碍相关,并且可以预测出血强度和患者结局。6小时内的早期血小板输注与严重出血患者死亡率的降低相关。

阻挡钉(Poller钉)怎么打?

干骺端长斜形骨折采用髓内钉固定的难点之一为骨折对线的恢复,由于骨折暴力因素或骨折周围肌肉的牵拉,断端间通常存在侧方移位趋势,在髓内钉置入时如何纠正骨折断端对位对线是临床较常见问题。

JNNP:高危痴呆症中年人的创伤和抑郁症状:预防性痴呆研究

目的:阿尔茨海默病(AD)和抑郁障碍曾经被认为是没有关系的。但是现在抑郁症被认为与AD密切相关。晚期抑郁症会使未来痴呆的风险增加1.65倍,同时也增加了从轻度认知障碍发展到痴呆的风险。这两种病理学的潜

Brit J Surg:创伤后长期使用阿片类药物的危险因素与患者结局

由此可见,创伤与长期使用阿片类药物有关。这些患者在创伤后6-18个月内仍有较高的死亡风险。

儿童期创伤对抗精神病药物疗效有影响?

抗精神病药物通常可有效改善精神分裂症患者的精神病性症状,是迄今为止研究最多并且被广泛推荐和使用的治疗精神分裂症谱系障碍的方法。尽管抗精神病药物在大部分患者身上行之有效,但据统计仍有约三分之一接受一线抗

Baidu
map
Baidu
map
Baidu
map